title: Genomic aberrations occurring in subsets of serrated colorectal lesions but not conventional adenomas.
abstract: A subset of aggressive colorectal cancers exhibit BRAF mutation, MLH1 methylation, and a CpG island methylator phenotype (CIMP), but precursors are poorly established. In this study, we determined the status of these markers in colorectal polyps and evaluated associated risk factors. The study included 771 polyp cases and 1,027 controls who were ages 24 to 80 years, part of a group health program, received a colonoscopy from 1998 to 2007, and completed a structured questionnaire assessing risk factors. Following standard pathology review, polyps were assayed for BRAF mutation (V600E) and tested for MLH1 and CIMP methylation, the latter including the genes, CACNA1G, IGF2, NEUROG1, RUNX3, and SOCS1. Polytomous logistic regression was used to estimate ORs and 95% confidence intervals for the association between molecularly defined subsets of polyps and potential risk factors. There were 580 conventional adenomas and 419 serrated lesions successfully assayed. For adenomas, the prevalence of each marker was ≤1%. In contrast, 55% of serrated lesions harbored mutant BRAF, 26% were CIMP-high, and 5% had methylated MLH1. In these lesions, the highest prevalence of markers was in sessile-serrated polyps (SSP) of ≥10 mm that were in the right-side/cecal regions of the colon. Risk factors for CIMP-high-serrated lesions included Caucasian race, current smoking status, and a history of polyps, whereas for serrated lesions with mutant BRAF, the significant risk factors were male sex, current smoking status, obesity, and a history of polyps. Our results suggest that SSPs and other large, right-sided serrated lesions have a unique molecular profile that is similar to CIMP-high, BRAF-mutated colorectal cancers.
authors.affiliation: Fred Hutchinson Cancer Research Center, Seattle 98109, USA. aburnett@fhcrc.org
authors.forename: Andrea N
authors.initials: AN
authors.lastname: Burnett-Hartman
authors.forename: Polly A
authors.initials: PA
authors.lastname: Newcomb
authors.forename: John D
authors.initials: JD
authors.lastname: Potter
authors.forename: Michael N
authors.initials: MN
authors.lastname: Passarelli
authors.forename: Amanda I
authors.initials: AI
authors.lastname: Phipps
authors.forename: Michelle A
authors.initials: MA
authors.lastname: Wurscher
authors.forename: William M
authors.initials: WM
authors.lastname: Grady
authors.forename: Lee-Ching
authors.initials: LC
authors.lastname: Zhu
authors.forename: Melissa P
authors.initials: MP
authors.lastname: Upton
authors.forename: Karen W
authors.initials: KW
authors.lastname: Makar
mesh_terms: D000236:Adenoma / Q000235:genetics*; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D016022:Case-Control Studies; D002869:Chromosome Aberrations; D003108:Colonic Diseases / Q000235:genetics*; D015179:Colorectal Neoplasms / Q000235:genetics*; D018899:CpG Islands; D019175:DNA Methylation; D005260:Female; D020869:Gene Expression Profiling; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D008297:Male; D008875:Middle Aged; D008957:Models, Genetic; D009154:Mutation; D011127:Polyps; D048493:Proto-Oncogene Proteins B-raf / Q000235:genetics; D012044:Regression Analysis; D012307:Risk Factors; D011795:Surveys and Questionnaires
chemical_list: C482119:BRAF protein, human; D048493:Proto-Oncogene Proteins B-raf
references.citation: Am J Surg Pathol. 2003 Jan;27(1):65-81
references.pmid: 12502929
references.citation: J Natl Cancer Inst. 2006 Dec 6;98(23):1731-8
references.pmid: 17148775
references.citation: J Mol Diagn. 2006 May;8(2):209-17
references.pmid: 16645207
references.citation: Am J Surg Pathol. 2008 Mar;32(3):407-12
references.pmid: 18300810
references.citation: Am J Gastroenterol. 2012 Sep;107(9):1315-29; quiz 1314, 1330
references.pmid: 22710576
references.citation: J Mol Diagn. 2007 Jul;9(3):305-14
references.pmid: 17591929
references.citation: Cancer Epidemiol Biomarkers Prev. 2011 Oct;20(10):2288-97
references.pmid: 21817125
references.citation: Gastroenterology. 2007 Oct;133(4):1077-85
references.pmid: 17698067
references.citation: Gastroenterology. 2010 Nov;139(5):1497-502
references.pmid: 20633561
references.citation: Gastroenterol Clin North Am. 2007 Dec;36(4):947-68, viii
references.pmid: 17996799
references.citation: Cancer Epidemiol Biomarkers Prev. 2008 Jul;17(7):1774-80
references.pmid: 18628431
references.citation: Cell. 1996 Oct 18;87(2):159-70
references.pmid: 8861899
references.citation: J Natl Cancer Inst. 2010 Jul 21;102(14):1012-22
references.pmid: 20587792
references.citation: Gut. 2004 Aug;53(8):1137-44
references.pmid: 15247181
references.citation: Biochim Biophys Acta. 2012 Jan;1825(1):77-85
references.pmid: 22056543
references.citation: Gastroenterology. 2010 Nov;139(5):1503-10, 1510.e1-3
references.pmid: 20643134
references.citation: Histopathology. 2007 Jan;50(1):113-30
references.pmid: 17204026
references.citation: Am J Gastroenterol. 2007 Aug;102(8):1739-44
references.pmid: 17433018
references.citation: Carcinogenesis. 2011 Mar;32(3):318-26
references.pmid: 21088106
references.citation: Am J Surg Pathol. 2010 Jul;34(7):927-34
references.pmid: 20551824
references.citation: Am J Pathol. 2002 Feb;160(2):529-36
references.pmid: 11839573
references.citation: Int J Cancer. 2008 Dec 1;123(11):2587-93
references.pmid: 18798261
references.citation: Int J Cancer. 2012 Aug 15;131(4):813-20
references.pmid: 21932420
references.citation: Gut. 2011 Mar;60(3):397-411
references.pmid: 21036793
references.citation: Am J Surg Pathol. 2006 Dec;30(12):1491-501
references.pmid: 17122504
references.citation: J Clin Pathol. 2009 Jun;62(6):516-8
references.pmid: 19126563
references.citation: Gut. 2012 Jun;61(6):847-54
references.pmid: 22427238
references.citation: J Pathol. 2001 Mar;193(3):286-94
references.pmid: 11241406
references.citation: Gastroenterology. 2006 Nov;131(5):1400-7
references.pmid: 17101316
references.citation: Nutr Cancer. 2011;63(4):583-92
references.pmid: 21598178
references.citation: J Mol Diagn. 2006 Nov;8(5):540-3
references.pmid: 17065421
references.citation: Int J Cancer. 2007 Feb 1;120(3):656-63
references.pmid: 17096326
references.citation: Cancer Epidemiol. 2010 Jun;34(3):338-44
references.pmid: 20381446
references.citation: Am J Surg Pathol. 2004 Apr;28(4):423-34
references.pmid: 15087661
references.citation: Am J Clin Pathol. 2006 Jun;125(6):813-4
references.pmid: 16690477
references.citation: J Pathol. 2001 Mar;193(3):283-5
references.pmid: 11241405
references.citation: Mod Pathol. 2010 Jan;23(1):151-6
references.pmid: 19855373
references.citation: Int J Epidemiol. 1997 Dec;26(6):1323-33
references.pmid: 9447413
references.citation: BMC Cancer. 2008 Sep 09;8:255
references.pmid: 18782444
references.citation: Hum Pathol. 2011 Jan;42(1):1-10
references.pmid: 20869746
references.citation: Clin Cancer Res. 2005 Feb 1;11(3):1203-9
references.pmid: 15709190
references.citation: Clin Gastroenterol Hepatol. 2011 Jan;9(1):42-6
references.pmid: 20888435
references.citation: Surg Oncol. 2007 Dec;16 Suppl 1:S7-9
references.pmid: 18023574
references.citation: PLoS One. 2010 Jul 16;5(7):e11636
references.pmid: 20661287
references.citation: PLoS One. 2011 Apr 05;6(4):e18571
references.pmid: 21483668
references.citation: Colorectal Dis. 2007 Jul;9(6):521-6
references.pmid: 17573746
references.citation: Nat Genet. 2006 Jul;38(7):787-93
references.pmid: 16804544
references.citation: Am J Pathol. 2003 Mar;162(3):815-22
references.pmid: 12598316